Table 1.
DASISION13 | ENESTnd14 | ||||
---|---|---|---|---|---|
Imatinib | Dasatinib | Imatinib | Nilotinib | ||
400 mg daily (n = 260) | 100 mg daily (n = 259) | 400 mg daily (n = 283) | 300 mg twice daily (n = 282) | 400 mg twice daily (n = 281) | |
Cumulative MMR at 5 y, % | 64 | 76 | 60 | 77 | 77 |
MR4.5 at 5 y, % | 33 | 42 | 31 | 54 | 52 |
Progression to AP/BC, % | 7 | 5 | 7 | 4 | 3 |
5-y OS (ITT), % | 90 | 91 | 92 | 94 | 96 |
5-y PFS, % | 86 | 85 | 91 | 92 | 96 |
AP, accelerated phase; BC, blast crisis; ITT, intention to treat.